Immunosenescence and inflammaging are now regarded as central biological mechanisms of ageing. The age-related altered immune system is both weakened and chronically activated – with consequences for susceptibility to infection, tumor development and the large group of inflammation-driven cardiometabolic diseases. In the following, central molecular mechanisms, clinical manifestations and potential intervention approaches are summarized based on current reviews and primary studies on immunosenescence, chronic inflammation and age-associated diseases.
Autoren
- Tanja Schliebe
Publikation
- Longevity-Special
You May Also Like
- Hormone balance and longevity
Ageing is not a substitution diagnosis
- Cardiovascular risk
Bad news for young men with T2D
- Case Report
6-year-old child with central retinal artery occlusion
- Low grade serous ovarian carcinoma (LGSOC)
Opening up new horizons through combination therapies
- Rare diseases
Yellow nail and Swyer-James syndrome
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort
Heart failure after myocardial infarction
- AI in neurology